Drops for corneal neovascularization.
Das
Madhusmita
M
Murthy
Somasheila
S
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D016510:Corneal Neovascularization / Q000188:drug therapy* / Q000473:pathology; D004311:Double-Blind Method; D006801:Humans; D009841:Oligonucleotides / Q000008:administration & dosage* / Q000009:adverse effects; D009883:Ophthalmic Solutions / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects
D020533:Angiogenesis Inhibitors; C540750:GS 101; D009841:Oligonucleotides; D009883:Ophthalmic Solutions